Consequently, silencing IKBKE has been reported to reduce the NF-κB activity and inhibit proliferation, clonogenicity, angiogenesis, migration, invasion, and metastasis in BC cells and many other cancer types [117,121]. This evidence concerns the gene IKBKE and breast cancer.